References
- Abdolrahimzadeh B, Piraino DC, Albanese G, Cruciani F, Rahimi S. Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography. Clin Ophthalmol. 2016;10:851–860. doi:10.2147/OPTH.S102830.
- Woodward LM. Ocular manifestations of phakomatoses. Int Ophthalmol Clin. 2014;54(3):105–110. doi:10.1097/IIO.0000000000000037.
- Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1–6. doi:10.1002/()1096-8628.
- Cawthon RM, Weiss R, Xu GF, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990;62(3):609. doi:10.1016/0092-8674(90)90253-B.
- Nandigam K, Mechtler LL, Smirniotopoulos JG. Neuroimaging of neurocutaneous diseases. Neurol Clin. 2014;32(1):159–192. doi:10.1016/j.ncl.2013.07.003.
- Armstrong GT, Localio AR, Feygin T, et al. Defining optic nerve tortuosity. AJNR Am J Neuroradiol. 2007;28:666–671.
- Viglianesi A, Messina M, Chiaramonte R, et al. An interpretation of optic nerve tortuosity. A case report. Neuroradiol J. 2009;22:381–385.
- Levin MH, Armstrong GT, Broad JH, et al. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Br J Ophthalmol. 2016;100(4):510–514. doi:10.1136/bjophthalmol-2015-306958.
- Ji J, Shimony J, Gao F, McKinstry RC, Gutmann DH. Optic nerve tortuosity in children with neurofibromatosis type 1. Pediatr Radiol. 2013;43(10):1336–1343. doi:10.1007/s00247-013-2694-1.